Consumer demand for lighter, more powerful handheld devices such as laptop computers and mobile phones is growing year on year. The EUREKA project 3D STRUCTURES has addressed one of the key requirements – cheaper and lighter batteries that last longer.

French lead partner SCPS (Societé de Conseil et de Prospective Scientifique S.A.) has developed a new kind of conductive metallic foam capable of replacing heavy metallic parts. A cylindrical block of foam is immersed in an aqueous solution t

ESA engineers are proposing a technique to enable a digital satellite radio service for European drivers – without the need to launch a single new satellite into orbit.

Commercial digital satellite radio is already a reality in the United States, using a costly set of dedicated satellites. The rival American services allow subscribing drivers to choose between numerous near-CD quality radio channels without tune-out or static.
Two parallel ESA studies have examined a lower-cost method o

Diabetes is a widespread illness affecting 5 per cent of the population. In diabetics the metabolism produces an excess of glucose in the blood and, as a result, a number of sufferers need doses of insulin which allows them to regulate their glucose levels.

Currently, the method of administering insulin to diabetic patients making use of emergency services for insulin dosage depends on the experience of the qualified personnel. That is, the same patient can receive different insulin doses,

Report envisions a future cyberinfrastructure that will “radically empower” the science and engineering community

The critical needs of science and rapid progress in information technology are converging to provide a unique opportunity to create and apply a sustained cyberinfrastructure that will “radically empower” scientific and engineering research and allied education, according to the National Science Foundation (NSF)’s Advisory Committee for Cyberinfrastructure. The committee

Stanford University Medical Center researchers have found that a recently discovered gene regulates HDL (high density lipoproteins) cholesterol, also known as “good” cholesterol. The study, published in the February issue of the Journal of Clinical Investigation, could lead to new therapies for heart disease, said lead author Thomas Quertermous, MD.

“This is a significant and unexpected finding, and the gene is going to be a real target for the prevention and treatment of heart disease,” sai

The use of combinations of antiretroviral drugs including nucleoside analogs, protease inhibitors (PIs) and reverse transcriptase inhibitors – collectively termed highly active anti-retroviral therapy (HAART) – has resulted in a dramatic improvement in health status for a large number of HIV-infected individuals.

Side effects in many users, however, cause non-adherence to treatment regimes and concern over their long-term use in the management of chronic HIV infection. The adverse effects o